Future research priorities for morbidity control of lymphedema

Background: Innovation in the treatment of lower extremity lymphedema has received low priority from the governments and pharmaceutical industry. Advancing lymphedema is irreversible and initiates fibrosis in the dermis, reactive changes in the epidermis and subcutis. Most medical treatments offered...

Full description

Bibliographic Details
Main Authors: S R Narahari, Madhur Guruprasad Aggithaya, Christine Moffatt, T J Ryan, Vaughan Keeley, B Vijaya, P Rajendran, S B Karalam, S Rajagopala, N K Kumar, K S Bose, K V Sushma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2017;volume=62;issue=1;spage=33;epage=40;aulast=Narahari